Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
Lanctôt et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:5-21.
ABSTRACT
| FULL TEXT
Association Between the {gamma}-Aminobutyric Acid A3 Receptor Gene and Multiple Sclerosis
Gade-Andavolu et al.
Arch Neurol 1998;55:513-516.
ABSTRACT
| FULL TEXT
Autoantibodies to Glutamate Decarboxylase in a Patient With Cerebellar Cortical Atrophy, Peripheral Neuropathy, and Slow Eye Movements
Honnorat et al.
Arch Neurol 1995;52:462-468.
ABSTRACT
Delayed Postanoxic Encephalopathy After Strangulation Serial Neuroradiological and Neurochemical Studies
Hori et al.
Arch Neurol 1991;48:871-874.
ABSTRACT
Cerebrospinal Fluid as a Reflector of Central Cholinergic and Amino Acid Neurotransmitter Activity in Cerebellar Ataxia
Manyam et al.
Arch Neurol 1990;47:1194-1199.
ABSTRACT
Cerebrospinal Fluid Amino Compounds in Parkinson's Disease: Alterations due to Carbidopa/Levodopa
Manyam et al.
Arch Neurol 1988;45:48-50.
ABSTRACT
{gamma}Aminobutyric Acid in CSF of Children With Febrile Seizures
Knight et al.
Arch Neurol 1985;42:474-475.
ABSTRACT
{gamma}-Aminobutyric Acid and Homovanillic Acid Concentration in the CSF of Patients With Senile Dementia of Alzheimer's Type
Zimmer et al.
Arch Neurol 1984;41:602-604.
ABSTRACT
Decreased CSF Concentrations of Homovanillic Acid and {gamma}-Aminobutyric Acid in Alzheimer's Disease: Age- or Disease-Related Modifications?
Bareggi et al.
Arch Neurol 1982;39:709-712.
ABSTRACT
Low CSF {gamma}-Aminobutyric Acid Levels in Parkinson's Disease: Effect of Levodopa and Carbidopa
Manyam
Arch Neurol 1982;39:391-392.
ABSTRACT
Central Nervous System {gamma}-Aminobutyric Acid Activity in Man: Relationship to Age and Sex as Reflected in CSF
Hare et al.
Arch Neurol 1982;39:247-249.
ABSTRACT
CSF Levels of {gamma}-Aminobutyric Acid in Schizophrenia: Low Values in Recently Ill Patients
van Kammen et al.
Arch Gen Psychiatry 1982;39:91-97.
ABSTRACT
Clinical Implications of Enzyme-Mediated Alterations of {gamma}-Aminobutyric Acid Content in Human CSF
Hare et al.
Arch Neurol 1981;38:491-494.
ABSTRACT
-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
-aminobutyric acid (GABA) in CSF were measured by the ion exchange-fluorometric method in 136 patients who underwent evaluation for neurologic disorders. In 19 patients with no organic neurologic or mental disorders who acted as normal controls, the mean ( ± SD) GABA level in CSF was 239 ± 76 picomoles/mL. Patients with acute hypoxic encephalopathy showed a mean GABA level in CSF higher than that of the controls, a difference that was statistically significant. In all the other disorders studied, the mean GABA level in CSF was either equal to or lower than that found in the controls. Statistically significant reductions of the GABA level in CSF were seen in patients with Huntington's disease, dementias, cerebellar cortical atrophy, multiple sclerosis, epilepsy, and Parkinson's disease.